期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

脂蛋白相关磷脂酶A2与冠心病关系的研究进展

下载PDF
导出
摘要 冠心病是动脉粥样硬化导致心脏缺血病变的最常见类型，病变发生发展过程中从脂质条纹到纤维斑块和粥样斑块乃至不稳定斑块的生成、破裂和血栓形成有各种炎症细胞和大量炎性递质参与。脂蛋白相关磷脂酶A2（LP—PLA2）在动脉粥样硬化形成和发展中具有促进作用，是一种与冠心病有关的新的炎症标志物。现将其相关的理论和最新的研究进展作一介绍。
作者 洪斌
机构地区 复旦大学附属中山医院青浦分院心内科
出处 《中国医药》 2012年第11期1479-1481,共3页 China Medicine
关键词 冠心病 磷脂酶A2 脂蛋白
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献22

  • 1Cao Y, Stafforini DM, Zimmerman GA, et al. Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated bymediators of inflammation. J Biol Chem, 1998,273 (7) : 4012-1020.
  • 2Zalewski A, Nelson JJ, Hegg L, et al. Lp-PLA2 : a new kid on the block. Clin Chem, 2006,52 ( 9 ) : 1645-1650.
  • 3Tselepis AD, Dentan C, Karabina SA, et al. PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme. Arterioscler Thmmb Vase Biol, 1995, 15(10) :1764-1773.
  • 4Brilakis ES, Khera A, McGuire DK, et al. Influence of race and sex on lipoprotein-associated phospholipase A2 levels: observations from the Dallas Heart Study. Atherosclerosis,2008, 199 ( 1 ) : 110- 115.
  • 5Winkler K, Winkelmann BR, Scharnagl H, et al. Platelet-activating factor acetylhydrolase activity indicates angiographic coronary artery disease independently of systemic inflammation and other risk factors: the Ludwigshafen Risk and Cardiovascular Health Study. Circulation,2005,111 (8) :980-987.
  • 6Packard CJ,O'Reilly DS, Caslake MJ, et al. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med,2000,343(16) :1148-1155.
  • 7Koenig W, Khuseyinova N, Lowel H, et al. Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southem Germany. Circulation, 2004,110 ( 14 ) : 1903- 1908.
  • 8Li N, Li S, Yu C, et al. Plasma Lp-PLA2 in acute coronary syndrome: association with major adverse cardiac events in a community-based cohort. Postgrad Med ,2010,122 (4) :200-205.
  • 9Herbert D, Aronow WH, Tang W, et al. Predictors of lipoproteinassociated phospholipase A 2 mass and activity levels among patients with stable and acute coronary syndrome: a credobiomarker study. JACC,2010,9(34) :112-115.
  • 10Tsimikas S, WiUeit J, Knoflach M, et al. Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-yearcardiovascular and non-cardiovascular mortality: results from the Bruneck study. Eur Heart J ,2009,30 ( 1 ) : 107-115.

二级参考文献9

  • 1梁茜,董吁钢,杨希立,杨光,崔金环.血管紧张素转换酶、内皮型一氧化氮合酶和载脂蛋白E基因多态性与冠心病的相关性[J].中山大学学报（医学科学版）,2006,27(4):396-400. 被引量：7
  • 2CORSETTI J P, RAINWATER D L, MOSS A J, et al. High lipoprotein-associated phospholipase A2 is a risk factor for recurrent coronary events in postinfarction patients [J]. ClinChem, 2006, 52 (7): 1331-1338.
  • 3BRILAKIS E S, MCCONNELL J P, LENNON R J, et al. Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up[J]. Eur Heart J, 2005, 26 (2) : 137-144.
  • 4陶文惠 黄文增.冠状动脉粥样硬化性心脏病30例的血清胆红素检测分析.新医学,1999,30(6):332-332.
  • 5NAGHAVI M, LIBBY P, FALK E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part Ⅰ [ J ]. Circulation, 2003, 108 (14) : 1664-1672.
  • 6MINTZ G S, NISSEN S E, ANDERSON W D, et al. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (ivus). A report of the american college of cardiology task force on clinical expert consensus documents developed in collaboration with the european society of cardiology endorsed by the society of cardiac angiography and interventions [ J ]. J Am Coll Cardiol, 2001, 37 (5) : 1478-1492.
  • 7DE KORTE C L, SIEREVOGEL M J, MASTIK F, et al. Identification of atherosclerotic plaque components with intravascular ultrasound elastography in vivo: a Yucatan pig study[J]. Circulation, 2002, 105(14): 1627-1630.
  • 8BALLANTYNE C M, HOOGEVEEN R C, BANG H, et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study [ J ]. Circulation, 2004, 109 (7): 837-842.
  • 9Winkler K.,Winkelmann B.R.,Scharnagl H.,刘文秀.血小板活化因子乙酰水解酶活性可独立于全身炎症和其他危险因素提示血管造影阳性冠状动脉疾病:Ludwigshafen风险和心血管健康状况研究[J].世界核心医学期刊文摘（心脏病学分册）,2005,0(8):34-35. 被引量：31

共引文献17

中国医药
2012年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部